US › Healthcare

Genetic Technologies Ltd (GENE)

US · Healthcare · Diagnostics & Research

$1,965.70+0.40%

Last close · 2026-09-17

Latest quarter · ended 2024-06-30

Revenue

$4.8M

Revenue YoY

+5.9%

Net profit

$-5.6M

EPS

$0.00

EPS estimate

$0.00

Net margin

-116.6%

Key statistics

Market cap

$3.7M

Forward P/E

0.0

P/B

3.29

Book value

$0.01

EPS (TTM)

$-0.02

52-week high

$2,044.50

52-week low

$1,714.92

50-day MA

$0.77

200-day MA

$1.10

Beta

0.48

Analyst view

with an average price target of $12.50.

Shareholding

Institutions

1.87%

Largest institutional holders

Fund	Stake
Rhumbline Advisers	0.07%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Genetic Technologies Ltd — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.